Targeted Disruption of Ing2 Results in Defective Spermatogenesis and Development of Soft-Tissue Sarcomas

被引:43
|
作者
Saito, Motonobu [1 ,3 ]
Kumamoto, Kensuke [1 ,3 ]
Robles, Ana I. [1 ]
Horikawa, Izumi [1 ]
Furusato, Bungo [2 ]
Okamura, Shu [1 ]
Goto, Akiteru [1 ]
Yamashita, Taro [1 ]
Nagashima, Makoto [1 ]
Lee, Tin-Lap [4 ]
Baxendale, Vanessa J. [4 ]
Rennert, Owen M. [4 ]
Takenoshita, Seiichi [3 ]
Yokota, Jun [5 ]
Sesterhenn, Isabell A. [2 ]
Trivers, Glenwood E. [1 ]
Hussain, S. Perwez [1 ]
Harris, Curtis C. [1 ]
机构
[1] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] Armed Forces Inst Pathol, Dept Genitourinary Pathol, Washington, DC 20306 USA
[3] Fukushima Med Univ, Sch Med, Dept Organ Regulatory Surg, Fukushima, Japan
[4] NICHHD, Lab Clin & Dev Genom, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA
[5] Natl Canc Ctr, Div Biol, Tokyo, Japan
来源
PLOS ONE | 2010年 / 5卷 / 11期
基金
美国国家卫生研究院;
关键词
HISTONE-DEACETYLASE INHIBITOR; CHROMOSOME LONG ARM; TUMOR-SUPPRESSOR; GERM-CELL; CHROMATIN MODIFICATION; TESTICULAR CANCER; EPIGENETIC EVENTS; MEIOTIC PROPHASE; MALE-INFERTILITY; GENE-EXPRESSION;
D O I
10.1371/journal.pone.0015541
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
ING2 (inhibitor of growth family, member 2) is a member of the plant homeodomain (PHD)-containing ING family of putative tumor suppressors. As part of mSin3A HDAC corepressor complexes, ING2 binds to tri-methylated lysine 4 of histone H3 (H3K4me3) to regulate chromatin modification and gene expression. ING2 also functionally interacts with the tumor suppressor protein p53 to regulate cellular senescence, apoptosis and DNA damage response in vitro, and is thus expected to modulate carcinogenesis and aging. Here we investigate the developmental and physiological functions of Ing2 through targeted germline disruption. Consistent with its abundant expression in mouse and human testes, male mice deficient for Ing2 showed abnormal spermatogenesis and were infertile. Numbers of mature sperm and sperm motility were significantly reduced in Ing2(-/-) mice (similar to 2% of wild type, P<0.0001 and similar to 10% of wild type, P<0.0001, respectively). Their testes showed degeneration of seminiferous tubules, meiotic arrest before pachytene stage with incomplete meiotic recombination, induction of p53, and enhanced apoptosis. This phenotype was only partially abrogated by concomitant loss of p53 in the germline. The arrested spermatocytes in Ing2(-/-) testes were characterized by lack of specific HDAC1 accumulation and deregulated chromatin acetylation. The role of Ing2 in germ cell maturation may extend to human ING2 as well. Using publicly available gene expression datasets, low expression of ING2 was found in teratozoospermic sperm (>3-fold reduction) and in testes from patients with defective spermatogenesis (>7-fold reduction in Sertoli-cell only Syndrome). This study establishes ING2 as a novel regulator of spermatogenesis functioning through both p53- and chromatin-mediated mechanisms, suggests that an HDAC1/ING2/H3K4me3-regulated, stage-specific coordination of chromatin modifications is essential to normal spermatogenesis, and provides an animal model to study idiopathic and iatrogenic infertility in men. In addition, a bona fide tumor suppressive role of Ing2 is demonstrated by increased incidence of soft-tissue sarcomas in Ing2(-/-) mice.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] CYTOGENETIC EVOLUTION IN PRIMARY TUMORS, LOCAL RECURRENCES, AND PULMONARY METASTASES OF 2 SOFT-TISSUE SARCOMAS
    ORNDAL, C
    MANDAHL, N
    WILLEN, H
    RYDHOLM, A
    MITELMAN, F
    CLINICAL & EXPERIMENTAL METASTASIS, 1993, 11 (05) : 401 - 408
  • [42] HUMAN MSX2 GENE-EXPRESSION IN VARIOUS BONE AND SOFT-TISSUE SARCOMAS
    SUZUKI, M
    TANAKA, M
    NAITO, Y
    KIYOKAWA, E
    IWASE, T
    YOSHIDA, H
    OGAWA, H
    KINO, I
    SUGIMURA, H
    MEDICAL SCIENCE RESEARCH, 1994, 22 (09): : 649 - 651
  • [43] Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort
    Italiano, A.
    Bessede, A.
    Pulido, M.
    Bompas, E.
    Piperno-Neumann, S.
    Chevreau, C.
    Penel, N.
    Bertucci, F.
    Toulmonde, M.
    Bellera, C.
    Guegan, J. P.
    Rey, C.
    Sautes-Fridman, C.
    Bougouin, A.
    Cantarel, C.
    Kind, M.
    Spalato, M.
    Dadone-Montaudie, B.
    Le Loarer, F.
    Blay, J. Y.
    Fridman, W. H.
    NATURE MEDICINE, 2022, 28 (06) : 1199 - +
  • [44] P53 MUTATION AND MDM2 AMPLIFICATION IN HUMAN SOFT-TISSUE SARCOMAS
    LEACH, FS
    TOKINO, T
    MELTZER, P
    BURRELL, M
    OLINER, JD
    SMITH, S
    HILL, DE
    SIDRANSKY, D
    KINZLER, KW
    VOGELSTEIN, B
    CANCER RESEARCH, 1993, 53 (10) : 2231 - 2234
  • [45] EXPRESSION OF DISIALOGANGLIOSIDES GD2 AND GD3 ON HUMAN SOFT-TISSUE SARCOMAS
    CHANG, HR
    CORDONCARDO, C
    HOUGHTON, AN
    CHEUNG, NKV
    BRENNAN, MF
    CANCER, 1992, 70 (03) : 633 - 638
  • [46] Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort
    A. Italiano
    A. Bessede
    M. Pulido
    E. Bompas
    S. Piperno-Neumann
    C. Chevreau
    N. Penel
    F. Bertucci
    M. Toulmonde
    C. Bellera
    J. P. Guegan
    C. Rey
    C. Sautès-Fridman
    A. Bougoüin
    C. Cantarel
    M. Kind
    M. Spalato
    B. Dadone-Montaudie
    F. Le Loarer
    J. Y. Blay
    W. H. Fridman
    Nature Medicine, 2022, 28 : 1199 - 1206
  • [47] LONG-TERM RESULTS OF NEUTRON-BOOST AND NEUTRON-BOOST IRRADIATION OF SOFT-TISSUE SARCOMAS
    SCHMITT, G
    PAPE, H
    ZAMBOGLOU, N
    STRAHLENTHERAPIE UND ONKOLOGIE, 1990, 166 (01): : 61 - 62
  • [48] Epidemiology of bone and soft-tissue sarcomas: A two-decade analysis of the surveillance, epidemiology, and end results program
    El Beaino, Marc
    Baum, Rachel
    Connors, Katherine M.
    Masrouha, Karim
    Lozano-Calderon, Santiago A.
    Lin, Patrick P.
    CANCER RESEARCH, 2024, 84 (06)
  • [49] RESULTS OF TOTAL LUNG IRRADIATION AND CHEMOTHERAPY IN COMPARISON WITH PARTIAL LUNG IRRADIATION IN METASTATIC UNDIFFERENTIATED SOFT-TISSUE SARCOMAS
    ZAMBOGLOU, N
    FURST, G
    PAPE, H
    BANNACH, B
    MOLLS, M
    SCHMITT, G
    STRAHLENTHERAPIE UND ONKOLOGIE, 1988, 164 (07) : 386 - 392
  • [50] INTERLEUKIN-2 PRODUCTION BY PERIPHERAL-BLOOD LYMPHOCYTES FROM PATIENTS WITH SOFT-TISSUE SARCOMAS
    BEREZHNAYA, NM
    GORETZKY, BA
    CONOVALENKO, VF
    PALIVETZ, AY
    TOLSTOPYATOV, BA
    EKSPERIMENTALNAYA ONKOLOGIYA, 1987, 9 (04): : 60 - 62